Covetrus Inc. (CVET): Price and Financial Metrics
GET POWR RATINGS... FREE!
CVET POWR Grades
- Value is the dimension where CVET ranks best; there it ranks ahead of 85.51% of US stocks.
- The strongest trend for CVET is in Momentum, which has been heading down over the past 31 weeks.
- CVET ranks lowest in Quality; there it ranks in the 16th percentile.
CVET Stock Summary
- With a one year PEG ratio of 3,619.07, Covetrus Inc is expected to have a higher PEG ratio (a measure of how expensive a stock is relative to its expected earnings growth) than 98.68% of US stocks.
- CVET's went public 2.36 years ago, making it older than merely 5.35% of listed US stocks we're tracking.
- The price/operating cash flow metric for Covetrus Inc is higher than 91.55% of stocks in our set with a positive cash flow.
- If you're looking for stocks that are quantitatively similar to Covetrus Inc, a group of peers worth examining would be RDFN, OXM, RIOT, RPT, and MTSI.
- Visit CVET's SEC page to see the company's official filings. To visit the company's web site, go to www.covetrus.com.
CVET Price Target
For more insight on analysts targets of CVET, see our CVET price target page. And for a list of of all stocks sorted by upside potential based on analyst target price, see our Top Price Target page.
| Average Price Target | $34.60 | Average Broker Recommendation | 1.67 (Moderate Buy) |
CVET Stock Price Chart Interactive Chart >
CVET Price/Volume Stats
| Current price | $27.71 | 52-week high | $40.78 |
| Prev. close | $27.60 | 52-week low | $16.97 |
| Day low | $27.18 | Volume | 170,020 |
| Day high | $27.95 | Avg. volume | 740,872 |
| 50-day MA | $28.06 | Dividend yield | N/A |
| 200-day MA | $28.89 | Market Cap | 3.78B |
Covetrus Inc. (CVET) Company Bio
Covetrus, Inc. engages in developing technologies and services for animal health industry. It also provides products, software, and services to help drive improved patient health, strong client relationships, and successful financial outcomes for veterinary professionals. The company was founded by Benjamin J. Shaw in 2014 and is headquartered in Portland, ME.
CVET Price Forecast Based on DCF Valuation
| Current Price | DCF Fair Value Target: | Forecasted Gain: |
| $27.71 | $0 | -100% |
We started the process of determining a valid price forecast for Covetrus Inc with a discounted cash flow analysis -- the results of which can be found in the table below. To summarize, we found that Covetrus Inc ranked in the 0th percentile in terms of potential gain offered. We should note, though, that all scenearios modelled for this stock suggest it is overvalued. As for the metrics that stood out in our discounted cash flow analysis of Covetrus Inc, consider:
- In the past 2.36 years, Covetrus Inc has a compound free cash flow growth rate of -0.6%; that's higher than only 1.62% of free cash flow generating stocks in the Technology sector.
- Covetrus Inc's effective tax rate, as measured by taxes paid relative to net income, is at 0 -- greater than only 0% of US stocks with positive free cash flow.
| Terminal Growth Rate in Free Cash Flow | Return Relative to Current Share Price |
| 0% | -100% |
| 1% | -100% |
| 2% | -100% |
| 3% | -100% |
| 4% | -100% |
| 5% | -100% |
Want more companies with a valuation profile/forecast similar to that of Covetrus Inc? See BAND, BHAT, CHWY, GAIA, and GB.
Latest CVET News From Around the Web
Below are the latest news stories about Covetrus Inc that investors may wish to consider to help them evaluate CVET as an investment opportunity.
Covetrus Integrates Prescription and Practice Management TechnologiesCovetrus enhanced their leading practice management software to help veterinary clinics compete online and deliver more complete healthcare. |
Strength Seen in Covetrus (CVET): Can Its 5.6% Jump Turn into More Strength?Covetrus (CVET) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock suggests that there could be more strength down the road. |
Covetrus (CVET) Q1 Earnings and Revenues Beat EstimatesCovetrus (CVET) delivered earnings and revenue surprises of 22.22% and 1.84%, respectively, for the quarter ended March 2021. Do the numbers hold clues to what lies ahead for the stock? |
Covetrus Announces Financial Results for First Quarter of 2021Covetrus, Inc. (Nasdaq: CVET), announced financial results for the first quarter of 2021, which ended March 31, 2021. |
Covetrus, Inc. to Host Earnings CallNEW YORK, NY / ACCESSWIRE / May 6, 2021 / Covetrus, Inc. (NASDAQ:CVET) will be discussing their earnings results in their 2021 First Quarter Earnings call to be held on May 6, 2021 at 4:30 PM Eastern Time. |
CVET Price Returns
| 1-mo | 5.72% |
| 3-mo | -7.57% |
| 6-mo | 1.13% |
| 1-year | 59.80% |
| 3-year | N/A |
| 5-year | N/A |
| YTD | -3.58% |
| 2020 | 117.73% |
| 2019 | N/A |
| 2018 | N/A |
| 2017 | N/A |
| 2016 | N/A |
Loading social stream, please wait...